Oral Penicillin and Penicillin Levels in Venous Umbilical Cord Blood
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00823433 |
Recruitment Status :
Terminated
(Insufficient enrollment.)
First Posted : January 15, 2009
Last Update Posted : November 4, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Group B Streptococcus | Drug: oral penicillin V | Early Phase 1 |
According to the CDC, before screening for GBS colonization was implemented, early onset GBS disease occurred at a rate of 1.5-2 per 1,000 live births. Antibiotic treatment for GBS colonized women according to guideline recommended by the American College of Obstetricians and Gynecologists (ACOG) decreases the risk for early onset neonatal GBS infection 10 fold. Unfortunately, many eligible women don't receive the full treatment protocol. Although the rate of early onset infection is low, the newborns of group B strep positive women who do not receive the recommended preventative antibiotics must undergo testing and extended observation.
This study will determine the level of antibiotics in the umbilical vein cord blood of newborn infants after the administration of penicillin orally while in labor and compare these levels to levels of penicillin in the umbilical vein cord blood of patients treated with intravenous penicillin in labor. Comparisons will be done through literature only; there will be no intravenous penicillin administration arm of the study.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 25 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Does Oral Penicillin Reach and Simulate Intravenous Penicillin Levels in Venous Umbilical Cord Blood of Laboring Pregnant Patients? |
Study Start Date : | January 2009 |
Actual Primary Completion Date : | December 2009 |
Actual Study Completion Date : | December 2009 |

Arm | Intervention/treatment |
---|---|
Experimental: Oral Penicillin
2 grams of oral penicillin V given within 4 hours of delivery
|
Drug: oral penicillin V
2 grams of oral penicillin V given within 4 hours of delivery. |
- The level of antibiotics in the umbilical vein cord blood of newborn infants after the administration of penicillin orally while in labor. [ Time Frame: after delivery ]
- Compare levels of penicillin in the umbilical cord blood of women who received oral penicillin to the levels of women who received intravenous penicillin in labor. Comparisons will be done through literature only. [ Time Frame: after delivery ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- pregnant women admitted for delivery or for induction of labor
- singleton pregnancy
- 18 years old or older
- beyond 36 weeks gestation
- able to comprehend study and give informed consent
Exclusion Criteria:
- known history of beta-lactam antibiotic allergy
- impaired renal function
- multiple gestation
- current use of antibiotics
- plan to bank cord blood after delivery

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00823433
United States, Michigan | |
William Beaumont Hospital | |
Royal Oak, Michigan, United States, 48073 |
Principal Investigator: | John E Uckele, MD | William Beaumont Hospitals |
Responsible Party: | John Uckele, Attending Physician, William Beaumont Hospitals |
ClinicalTrials.gov Identifier: | NCT00823433 |
Other Study ID Numbers: |
2008-183 |
First Posted: | January 15, 2009 Key Record Dates |
Last Update Posted: | November 4, 2016 |
Last Verified: | November 2016 |
Penicillin Group B Streptococcus Pregnancy Labor |
Penicillins Penicillin V Anti-Bacterial Agents Anti-Infective Agents |